On March 28th the European Pulmonary Fibrosis Federation launched a series of monthly and free webinars for the Pulmonary Fibrosis community – including patients, carers, patient advocates and HCPs – in the run up to the European Pulmonary Fibrosis Patient Summit taking place virtually in November 2022. The webinars & the summit will revolve around research, person-centred care, policy and advocacy on pulmonary fibrosis.
The second webinar will be held on: May 9th 2022 | 19:00-20:00 CET | 18.00-19.00 GMT | 1-2 PM Eastern Time.
Dr Richard Allen will discuss the genetics of pulmonary fibrosis: He will introduce genetics and how generic variations can lead to disease, discuss the genetic changes associated with IPF and other forms of pulmonary fibrosis, and explore the implications for new treatments and for familial pulmonary fibrosis patients. His talk will draw on his research funded by Action for Pulmonary Fibrosis, UK. The presentation is aimed mainly at patients & their families, although HCPs may also find it interesting. As always, there will be opportunities for questions & answers.
The webinar will be moderated by Steve Jones, EU-IPFF President.
The live webinar will be held in English. The recordeding will be released later with subtitles in various languages.
This series of webinars are kindly supported by an unrestricted grant from Boehringer Ingelheim and the Roche Group.
Sponsors of the 2nd European Pulmonary Fibrosis Patient Summit 2022: Boehringer Ingelheim, Chiesi & CSL Behring.
The data provided by you (name & email address) will be used exclusively to inform you about our activities, future events, our webinars and, if applicable, other events and projects relevant to the PF community, and will not be passed on to third parties under any circumstances. By registering for this webinar, you consent to these terms. Consent for use of your data for those purposes can be withdrawn any time by an email to firstname.lastname@example.org.